US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

16.77

-0.5900-3.40%

Post-market: 16.770.00000.00%16:04 EDT

Volume:12.87K

Turnover:217.62K

Market Cap:5.67B

PE:187.40

High:17.19

Open:16.72

Low:16.31

Close:17.36

Loading ...

Overview Company News Filings

Telix Opens Manufacturing Facility in Japan

MT Newswires Live

Telix Pharmaceuticals Initiated at Outperform by Wedbush

Telix Pharmaceuticals Ltd : Wedbush Initiates Coverage With Outperform Rating; Target Price $22.00

THOMSON REUTERS

Wedbush Initiates Telix Pharmaceuticals at Outperform With $22 Price Target

MT Newswires Live

Telix Pharmaceuticals Issues New Share Appreciation Rights

Telix Pharmaceuticals Announces Director Change

Telix Pharmaceuticals’ AGM Resolutions Successfully Passed

Telix Pharmaceuticals to Release Shares from Voluntary Escrow

Telix Pharmaceuticals Expands Market Presence with New Securities Quotation

Telix Pharmaceuticals Issues New Equity Securities

Telix Pharmaceuticals Announces Cessation of Share Rights

Wilsons Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)

UBS Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

Telix Pharmaceuticals Announces Board Resignation of Anne Whitaker

Telix Pharmaceuticals Secures Marketing Authorization for Prostate Cancer Imaging Agent in France

MT Newswires Live

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

Telix Pharmaceuticals Says US FDA Ruled New Drug Application for Brain Cancer Imaging Agent 'Cannot be Approved in Current Form'; Shares Down 7%

MT Newswires Live

Telix Pharmaceuticals Ltd. (TLPPF) Receives a Buy from UBS

Bell Potter Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)

Telix Pharmaceuticals to Release Shares from Voluntary Escrow

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/TLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":16.77,"timestamp":1749240000000,"preClose":17.36,"halted":0,"volume":12873,"hourTrading":{"tag":"盘后","latestPrice":16.77,"preClose":16.77,"latestTime":"16:04 EDT","volume":34,"amount":578.18,"timestamp":1749240257024},"delay":0,"floatShares":275137421,"shares":338109048,"eps":0.089486,"marketStatus":"Market Closed","change":-0.59,"latestTime":"06-06 16:00:00 EDT","open":16.72,"high":17.1899,"low":16.31,"amount":217616.5022,"amplitude":0.050685,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.089486,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":17.36,"preHourTrading":{"tag":"盘前","latestPrice":17.03,"preClose":17.36,"latestTime":"09:28 EDT","volume":200,"amount":3406,"timestamp":1749216480030},"postHourTrading":{"tag":"盘后","latestPrice":16.77,"preClose":16.77,"latestTime":"16:04 EDT","volume":34,"amount":578.18,"timestamp":1749240257024},"volumeRatio":1.2461762087873647},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":275137421,"roa":"5.33%","roe":"13.92%","lyrEps":0.093266,"volumeRatio":1.2461762087873647,"shares":338109048,"dividePrice":0,"high":17.1899,"amplitude":0.050685,"preClose":17.36,"low":16.31,"week52Low":13.61,"pbRate":"15.37","psRate":"11.15","week52High":30.36,"institutionHeld":0,"latestPrice":16.77,"eps":0.089486,"divideRate":0,"volume":12873,"delay":0,"ttmEps":0.089486,"open":16.72,"prevYearClose":15.4,"prevWeekClose":16.9899,"prevMonthClose":16.9899,"prevQuarterClose":16.76,"fiveDayClose":16.9899,"twentyDayClose":17.05,"sixtyDayClose":17.16},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541004852","title":"Telix Opens Manufacturing Facility in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2541004852","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541004852?lang=en_us&edition=fundamental","pubTime":"2025-06-06 07:13","pubTimestamp":1749165197,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) said it has opened a cyclotron facility, Telix Manufacturing Solutions, in Yokohama, Japan, according to a Thursday statement by the company.The facility will support c","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","TLX","BK7067","BK4139"],"gpt_icon":0},{"id":"2541402051","title":"Telix Pharmaceuticals Initiated at Outperform by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2541402051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541402051?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:07","pubTimestamp":1749125220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 05, 2025 08:07 ET (12:07 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"gpt_icon":0},{"id":"2541702447","title":"Telix Pharmaceuticals Ltd : Wedbush Initiates Coverage With Outperform Rating; Target Price $22.00","url":"https://stock-news.laohu8.com/highlight/detail?id=2541702447","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541702447?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:55","pubTimestamp":1749120927,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nFWN3S80BN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TLX.AU","BK7067","BK4139","TLX"],"gpt_icon":0},{"id":"2541024405","title":"Wedbush Initiates Telix Pharmaceuticals at Outperform With $22 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2541024405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541024405?lang=en_us&edition=fundamental","pubTime":"2025-06-05 18:55","pubTimestamp":1749120927,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (TLX) has an average rating of overweight and mean price target of $21.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX"],"gpt_icon":0},{"id":"2541920310","title":"Telix Pharmaceuticals Issues New Share Appreciation Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2541920310","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541920310?lang=en_us&edition=fundamental","pubTime":"2025-06-05 07:09","pubTimestamp":1749078559,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an update. Telix Pharmaceuticals Limited announced the issuance of 1,541,188 share appreciation r...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-share-appreciation-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-share-appreciation-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0},{"id":"2537571639","title":"Telix Pharmaceuticals Announces Director Change","url":"https://stock-news.laohu8.com/highlight/detail?id=2537571639","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537571639?lang=en_us&edition=fundamental","pubTime":"2025-05-22 06:47","pubTimestamp":1747867631,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has provided an update. Telix Pharmaceuticals Limited announced the cessation of Harry Kevin McCann as a direct...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-director-change?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-director-change?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0},{"id":"2537677982","title":"Telix Pharmaceuticals’ AGM Resolutions Successfully Passed","url":"https://stock-news.laohu8.com/highlight/detail?id=2537677982","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2537677982?lang=en_us&edition=fundamental","pubTime":"2025-05-21 12:57","pubTimestamp":1747803441,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has shared an update. Telix Pharmaceuticals announced that all resolutions proposed at its Annual General Meeti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-agm-resolutions-successfully-passed?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-agm-resolutions-successfully-passed?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4195","AGM","BK4139","BK4229","TLX"],"gpt_icon":0},{"id":"2536142525","title":"Telix Pharmaceuticals to Release Shares from Voluntary Escrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2536142525","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536142525?lang=en_us&edition=fundamental","pubTime":"2025-05-19 06:58","pubTimestamp":1747609095,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) just unveiled an announcement. Telix Pharmaceuticals Limited announced the release of 684,437 ordinary shares f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-to-release-shares-from-voluntary-escrow-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-to-release-shares-from-voluntary-escrow-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0},{"id":"2535436354","title":"Telix Pharmaceuticals Expands Market Presence with New Securities Quotation","url":"https://stock-news.laohu8.com/highlight/detail?id=2535436354","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535436354?lang=en_us&edition=fundamental","pubTime":"2025-05-16 16:07","pubTimestamp":1747382833,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals Limited has announced the quotation of 139,383 ordinary fu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-expands-market-presence-with-new-securities-quotation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-expands-market-presence-with-new-securities-quotation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0},{"id":"2535351998","title":"Telix Pharmaceuticals Issues New Equity Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2535351998","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535351998?lang=en_us&edition=fundamental","pubTime":"2025-05-16 15:48","pubTimestamp":1747381713,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals Limited has announced the issuance of new ordinary f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-equity-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-issues-new-equity-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4215","TLX","EQR","BK4139","BK4588"],"gpt_icon":0},{"id":"2535351926","title":"Telix Pharmaceuticals Announces Cessation of Share Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2535351926","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535351926?lang=en_us&edition=fundamental","pubTime":"2025-05-16 15:48","pubTimestamp":1747381703,"startTime":"0","endTime":"0","summary":"An update from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals Limited has announced the cessation of 135,000 share rig...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-cessation-of-share-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-cessation-of-share-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"gpt_icon":0},{"id":"2534256844","title":"Wilsons Reaffirms Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2534256844","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534256844?lang=en_us&edition=fundamental","pubTime":"2025-05-12 07:36","pubTimestamp":1747006615,"startTime":"0","endTime":"0","summary":"Wilsons analyst Shane Storey maintained a Buy rating on Telix Pharmaceuticals (TLPPF – Research Report) on May 8 and set a price target of A$35.00....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wilsons-reaffirms-their-buy-rating-on-telix-pharmaceuticals-tlppf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wilsons-reaffirms-their-buy-rating-on-telix-pharmaceuticals-tlppf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF"],"gpt_icon":0},{"id":"2531217862","title":"UBS Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2531217862","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531217862?lang=en_us&edition=fundamental","pubTime":"2025-04-29 10:39","pubTimestamp":1745894387,"startTime":"0","endTime":"0","summary":"In a report released today, David Dai from UBS maintained a Buy rating on Telix Pharmaceuticals (TLPPF – Research Report), with a price target of A...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX"],"gpt_icon":0},{"id":"2531915702","title":"Telix Pharmaceuticals Announces Board Resignation of Anne Whitaker","url":"https://stock-news.laohu8.com/highlight/detail?id=2531915702","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531915702?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:57","pubTimestamp":1745884643,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals announced the resignation of Anne Whitaker from its board ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-board-resignation-of-anne-whitaker?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-announces-board-resignation-of-anne-whitaker?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0},{"id":"2531291299","title":"Telix Pharmaceuticals Secures Marketing Authorization for Prostate Cancer Imaging Agent in France","url":"https://stock-news.laohu8.com/highlight/detail?id=2531291299","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531291299?lang=en_us&edition=fundamental","pubTime":"2025-04-29 07:49","pubTimestamp":1745884196,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  received marketing authorization in France for Illuccix, its prostate cancer positron emission tomography  imaging agent, the company said in a statement Monday.Illucix is indicated in France for the detection and localization of prostate-specific membrane antigen-positive lesions in adults with prostate cancer, the statement said.The company is partnering with IRE Group subsidiary IRE ELiT to market and promote Illuccix in France, according to the statement.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7047","PET.AU","BK7067","TLX","PET","BK4192","TLX.AU"],"gpt_icon":0},{"id":"2531999262","title":"Telix's Illuccix PSMA-PET Imaging Agent Approved in France","url":"https://stock-news.laohu8.com/highlight/detail?id=2531999262","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531999262?lang=en_us&edition=fundamental","pubTime":"2025-04-29 06:30","pubTimestamp":1745879400,"startTime":"0","endTime":"0","summary":"New approval provides French hospitals and clinics with access to a provenPSMA-PET imaging agent. MELBOURNE, Australia, April 29, 2025  -- Telix Pharmaceuticals Limited  today announces that its prostate cancer PET1 imaging agent, Illuccix , has been granted marketing authorization in France by ANSM2 for the detection and localization of prostate-specific membrane antigen -positive lesions in adults with prostate cancer, a broad clinical label.Illuccix, after radiolabelling with gallium-68, is indicated in France for the detection of prostate-specific membrane antigen -positive lesions with PET in adults with prostate cancer  in the following clinical settings:. Identification of patients with PSMA-positive progressive metastatic castration-resistant prostate cancer  for whom PSMA-targeted therapy is indicated.With its broad indication and ready-to-use formulation, Illuccix is designed to support healthcare providers in delivering efficient and reliable imaging. The approval comes as d","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/telixs-illuccix-psma-pet-imaging-223000028.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BK4233","BK4109","BK4217","UK","TLX","BK4528","BK4543","TGA","TLX.AU","BK4205","BK4084","BK4141","PET","DCP","ASX","BCR","BK4526","BK4585","BK4533","PSA","BK4588","CE","BK4139","EEA","BK4144","BK4192"],"gpt_icon":0},{"id":"2530827498","title":"Telix Pharmaceuticals Says US FDA Ruled New Drug Application for Brain Cancer Imaging Agent 'Cannot be Approved in Current Form'; Shares Down 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530827498","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530827498?lang=en_us&edition=fundamental","pubTime":"2025-04-28 08:37","pubTimestamp":1745800678,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said the US Food and Drug Administration  ruled that its New Drug Application for TLX101-CDx, an investigational agent for the imaging of glioma, cannot be approved in its current form, according to a Monday filing with the Australian bourse.Glioma is a rare and life-threatening type of brain cancer.In its complete response letter, the FDA stated further confirmatory clinical evidence is necessary to proceed with the application, the filing said.The company plans to request a hearing with the FDA to review the basis for the decision, per the filing.Telix Pharmaceuticals shares were down 7% in morning trade on Monday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","TLX","BK4139"],"gpt_icon":0},{"id":"2529269091","title":"Telix Pharmaceuticals Ltd. (TLPPF) Receives a Buy from UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2529269091","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529269091?lang=en_us&edition=fundamental","pubTime":"2025-04-24 09:36","pubTimestamp":1745458578,"startTime":"0","endTime":"0","summary":"In a report released today, Marcus Curley from UBS maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/telix-pharmaceuticals-ltd-tlppf-receives-a-buy-from-ubs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/telix-pharmaceuticals-ltd-tlppf-receives-a-buy-from-ubs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX","BK4139"],"gpt_icon":0},{"id":"2529693237","title":"Bell Potter Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2529693237","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529693237?lang=en_us&edition=fundamental","pubTime":"2025-04-24 07:36","pubTimestamp":1745451415,"startTime":"0","endTime":"0","summary":"In a report released today, John Hester from Bell Potter maintained a Buy rating on Telix Pharmaceuticals Ltd. (TLPPF – Research Report), with a pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bell-potter-remains-a-buy-on-telix-pharmaceuticals-ltd-tlppf-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bell-potter-remains-a-buy-on-telix-pharmaceuticals-ltd-tlppf-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF","BK4139"],"gpt_icon":0},{"id":"2529711698","title":"Telix Pharmaceuticals to Release Shares from Voluntary Escrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2529711698","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529711698?lang=en_us&edition=fundamental","pubTime":"2025-04-24 06:47","pubTimestamp":1745448471,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd. ( ($AU:TLX) ) has issued an announcement. Telix Pharmaceuticals Limited has announced the release of 2,427,636 ordinary ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-to-release-shares-from-voluntary-escrow-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-to-release-shares-from-voluntary-escrow-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLX"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":119,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":3,"updateTime":1749182400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2025-06-06","current":173.121803,"percent":0.388489,"low":151.061716,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"high":205.576265,"avg":177.817132,"sd":12.490541,"marketCap":5638091901.1},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1}],"updateTime":1749346800671}}}